Status:
COMPLETED
Benefits of Tanning in Fibromyalgia Patients
Lead Sponsor:
Wake Forest University
Conditions:
Fibromyalgia Syndrome
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
* To establish whether ultraviolet light exposure acutely reduces perceptions of pain in patients with fibromyalgia. * To establish whether a series of UV light exposures has a cumulative effect on fi...
Detailed Description
Fibromyalgia is a common chronic disorder characterized by widespread pain and fatigue. It occurs primarily in women, especially women of childbearing age. The effectiveness of treatment for this diso...
Eligibility Criteria
Inclusion
- Fibromyalgia patients who meet the fibromyalgia criteria, and who have been diagnosed with fibromyalgia by a board certified rheumatologist. The fibromyalgia criteria {as defined by the American College of Rheumatology (ACR)} require the patient to have: at least 3 months of widespread pain defined as: bilateral; above and below the waist, including axial skeletal pain; and pain to palpation with 4kg of pressure at a minimum of 11 out of 18 predefined tender points.
- Ideally, patients should not be taking medication for treatment of fibromyalgia, and they should not be taking psychoactive medications on an as needed basis for treatment of fibromyalgia. However, if patients are taking psychoactive or other medications for the treatment of fibromyalgia, then they should be on a stable dose, defined as no change in dosage in the 4 weeks prior to study enrollment.
- Patients must agree to not partake in tanning bed UV exposure during the study.
Exclusion
- Fitzpatrick skin type 1 ("never tan, always burn")
- Past or present skin cancer
- Current use of photosensitizing drugs (current use of photosensitizing drugs will be evaluated via a patient questionnaire at time of patient enrollment - see Appendix 1),, psychoactive medications (not a stable dose, defined as no change in dosage in the 4 weeks prior to study enrollment), or illicit drugs
- Pregnant, planning to become pregnant, or breast feeding
- Significant visual discrimination of UV versus non-UV conditions
- Greater than 6 indoor tanning sessions over the past year
- Concurrent photosensitive disease, positive antinuclear antibody test, positive anti-Smith antibody test, or positive anti-dsDNA test.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00447083
Start Date
May 1 2005
End Date
September 1 2008
Last Update
November 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157